Article

This Web site is developed and maintained under the editorial direction of diagnosticimaging.com, the Web site of Diagnostic Imaging magazine and its related publications.

It is the goal of this Web site to be the Web’s most comprehensive and up-to-date source of information on radiofrequency ablation and other energy-based tumor ablation therapies.

Material for this site is developed by physicians and medical journalists. Material also comes from the pages of Diagnostic Imaging magazine and its related publications, from Oncology News International magazine, and from reports published at www.diagnosticimaging.com.

Editorial director:
     John C. Hayes, john.hayes@cmpmedica.com

Contributing editors:
     Sarah Jersild, sjersild@gmail.com
     H.A. Abella, habella@cmp.com

Copy editors:
     Kathleen Lawrence
     Frances Taylor

Web Master:
     DIWebMaster@cmp.comEditorial questions: Inquiries should be directed to the Editor, Diagnostic Imaging, 600 Harrison St., San Francisco, CA 94107, 415/947-6472, john.hayes@cmpmedica.com.

 

DISCLOSURE: The editorial material on this Web site is published solely by CMP Healthcare Media Group LLC, the publisher of Diagnostic Imaging. CMP Media LLC does not endorse the appropriateness of or are responsible for any actions taken by third parties on the basis of material available at this Web site.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.